COVID-19 Vaccination in Patients with Inborn Errors of Immunity Reduces Hospitalization and Critical Care Needs Related to COVID-19: a USIDNET Report

and promotion of well-being Epidemiology Logistic regression 32 Biomedical and Clinical Sciences Infectious disease (medical specialty) FOS: Health sciences Immunization; Immunodeficiency; Outcomes; Viruses: respiratory diseases Pediatrics Disease 3202 Clinical Sciences Internal medicine Outcome Pediatric Immunology and Microbiology Vaccines 0303 health sciences Vaccination Life Sciences 3 Good Health and Well Being 3204 Immunology Hospitalization Infectious Diseases 3.4 Vaccines 1107 Immunology Medicine Emergency medicine Original Article Infection COVID-19 Vaccines Critical Care Immunology 610 Outcomes Coronavirus Disease 2019 Research Vaccine Related 03 medical and health sciences Clinical Research Biodefense Health Sciences Epidemiology and Pathogenesis of Respiratory Viral Infections Immunodeficiency Humans 3 Prevention of disease and conditions Prevention Genetic Basis of Primary Immunodeficiency Disorders FOS: Clinical medicine Immunity COVID-19 Viruses: respiratory diseases Coronavirus disease 2019 (COVID-19) Emerging Infectious Diseases Immunization
DOI: 10.1007/s10875-023-01613-5 Publication Date: 2024-04-05T05:01:46Z
AUTHORS (158)
ABSTRACT
Abstract Background The CDC and ACIP recommend COVID-19 vaccination for patients with inborn errors of immunity (IEI). Not much is known about vaccine safety in IEI, whether attenuates infection severity IEI. Objective To estimate examine effect on outcomes Methods We built a secure registry database conjunction the US Immunodeficiency Network to frequency indicators effectiveness IEI patients. opened January 1, 2022, closed August 19, 2022. Results Physicians entered data 1245 from 24 countries. most common diagnoses were antibody deficiencies (63.7%). At least one was administered 806 (64.7%), 216 received prior development COVID-19. vaccines mRNA-based (84.0%). Seventeen reported seek outpatient clinic or emergency room care vaccine-related complication, patient hospitalized symptomatic anemia. Eight hundred twenty-three (66.1%) experienced infection. Of these, 156 required hospitalization (19.0%), 47 ICU (5.7%), 28 died (3.4%). Rates (9.3% versus 24.4%, p < 0.001), admission (2.8% 7.6%, = 0.013), death (2.3% 4.3%, 0.202) who had lower In adjusted logistic regression analysis, not having at significantly increased odds admission. Conclusion Vaccination population appears safe severity.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (28)
CITATIONS (5)